| scholarly article | Q13442814 |
| P50 | author | Benjamín Aguilera-Venegas | Q47504612 |
| Vicente J. Arán | Q53792024 | ||
| P2093 | author name string | Claudio Olea-Azar | |
| Hernán Speisky | |||
| P2860 | cites work | Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain | Q21092283 |
| The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease | Q22065799 | ||
| Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design | Q24616801 | ||
| Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects | Q24685669 | ||
| Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors | Q27618611 | ||
| Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole | Q27660510 | ||
| Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress | Q28144631 | ||
| A critical review on Chagas disease chemotherapy | Q28216601 | ||
| Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism | Q28275518 | ||
| Synthesis and antitrypanosomal evaluation of E-isomers of 5-nitro-2-furaldehyde and 5-nitrothiophene-2-carboxaldehyde semicarbazone derivatives. structure-activity relationships | Q28377959 | ||
| Computational identification of uncharacterized cruzain binding sites | Q28473888 | ||
| Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51 | Q28481694 | ||
| Mixed Valence Chemistry-A Survey and Classification | Q30050358 | ||
| The fairytale of the GSSG/GSH redox potential | Q30423234 | ||
| 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. | Q31917058 | ||
| "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease | Q33634169 | ||
| Chagas disease has now gone global | Q33900069 | ||
| Betraying the parasite's redox system: diaryl sulfide-based inhibitors of trypanothione reductase: subversive substrates and antitrypanosomal properties | Q34007340 | ||
| Substrate specificity of trypanothione reductase | Q34064252 | ||
| A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi | Q34139347 | ||
| Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation | Q34228648 | ||
| Discovery of nitroheterocycles active against African trypanosomes. In vitro screening and preliminary SAR studies | Q34318962 | ||
| Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. | Q34515509 | ||
| Trypanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas' disease evolution | Q35137508 | ||
| Pharmacological properties of indazole derivatives: recent developments | Q36002995 | ||
| A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes | Q36516224 | ||
| Chemical-biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target | Q36594213 | ||
| Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification | Q37202974 | ||
| Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes. | Q37239664 | ||
| From nature to drug discovery: the indole scaffold as a 'privileged structure'. | Q37516118 | ||
| Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches | Q37629919 | ||
| Low-molecular-mass antioxidants in parasites. | Q37952777 | ||
| Redox-active antiparasitic drugs | Q37961952 | ||
| Redox metabolism in mitochondria of trypanosomatids | Q38048340 | ||
| Trypanothione: a unique bis-glutathionyl derivative in trypanosomatids | Q38080372 | ||
| Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery | Q38081532 | ||
| Chagas disease: a Latin American health problem becoming a world health problem | Q38433442 | ||
| Cardiovascular effects of a novel selective Rho kinase inhibitor, 2-(1H-indazole-5-yl)amino-4-methoxy-6-piperazino triazine (DW1865). | Q39200609 | ||
| Biological and chemical study of fused tri- and tetracyclic indazoles and analogues with important antiparasitic activity. | Q39348497 | ||
| Molecular dynamics simulations of peptide inhibitors complexed with Trypanosoma cruzi trypanothione reductase. | Q39462850 | ||
| The biochemistry of the mode of action of drugs and the detoxication mechanisms in Trypanosoma cruzi | Q39471502 | ||
| Potent 5-nitrofuran derivatives inhibitors of Trypanosoma cruzi growth: electrochemical, spectroscopic and biological studies | Q39563227 | ||
| Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. | Q39587113 | ||
| ESR, electrochemical, molecular modeling and biological evaluation of 4-substituted and 1,4-disubstituted 7-nitroquinoxalin-2-ones as potential anti-Trypanosoma cruzi agents. | Q39607363 | ||
| The metabolic activation of nitroheterocyclic therapeutic agents | Q39654207 | ||
| InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives | Q39673118 | ||
| Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226. | Q40078441 | ||
| Synthesis and structure-activity relationships of novel pyrimido[1,2-b]indazoles as potential anticancer agents against A-549 cell lines | Q40146801 | ||
| Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studies | Q40315286 | ||
| Synthesis and biological properties of new 5-nitroindazole derivatives | Q40439086 | ||
| Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity | Q41824183 | ||
| Applications of Electron Spin Resonance Spectrometry for Reactive Oxygen Species and Reactive Nitrogen Species Research | Q42735044 | ||
| Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides | Q42969142 | ||
| Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved? | Q43152757 | ||
| ESR and electrochemical study of 1,2-disubstituted 5-nitroindazolin-3-ones and 2-substituted 3-alkoxy-5-nitro-2H-indazoles: reactivity and free radical production capacity in the presence of biological systems | Q43234889 | ||
| New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies | Q43245430 | ||
| Assaying phenothiazine derivatives as trypanothione reductase and glutathione reductase inhibitors by theoretical docking and molecular dynamics studies | Q43267557 | ||
| Trypanosoma cruzi trypanothione reductase is inactivated by peroxidase-generated phenothiazine cationic radicals | Q43592131 | ||
| Specific peptide inhibitors of trypanothione reductase with backbone structures unrelated to that of substrate: potential rational drug design lead frameworks | Q43594914 | ||
| CoMFA-SIMCA model for antichagasic nitrofurazone derivatives | Q43608956 | ||
| Discovery of novel indazole-linked triazoles as antifungal agents | Q43629548 | ||
| Voltammetric behavior of benznidazole at a DNA-electrochemical biosensor | Q44026358 | ||
| Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead | Q44055708 | ||
| Electrochemical characteristics of nitroheterocyclic compounds of biological interest. VIII. Stability of nitro radical anions from cyclic voltammetric studies | Q44082105 | ||
| Electrochemical studies of nitroheterocyclic compounds of biological interest. VII. Effect of electrode material | Q44122142 | ||
| Evidence for the role of a peroxidase compound I-type intermediate in the oxidation of glutathione, NADH, ascorbate, and dichlorofluorescin by cytochrome c/H2O2. Implications for oxidative stress during apoptosis | Q44441838 | ||
| Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates | Q46182270 | ||
| Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones | Q46190892 | ||
| Study of 5-nitroindazoles' anti-Trypanosoma cruzi mode of action: electrochemical behaviour and ESR spectroscopic studies. | Q46398127 | ||
| In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles | Q46427027 | ||
| Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents | Q46734086 | ||
| ESR and electrochemical study of 5-nitroindazole derivatives with antiprotozoal activity | Q46847789 | ||
| A 1H, 13C and 15N NMR study in solution and in the solid state of six N-substituted pyrazoles and indazoles | Q46881592 | ||
| Electrochemical behavior of indolone-N-oxides: relationship to structure and antiplasmodial activity | Q48014577 | ||
| Comparative spectroscopic and electrochemical study of nitroindazoles: 3-alcoxy, 3-hydroxy and 3-oxo derivatives. | Q50912453 | ||
| Correlations Genuine and Spurious in Pearson and Yule | Q55951442 | ||
| Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug | Q56985079 | ||
| An Estimate of the Burden of Chagas Disease in the United States | Q57985309 | ||
| Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs | Q58842866 | ||
| Synthesis and enzymology of modifiedN-benzyloxycarbonyl-L-cysteinylglycyl-3,3-dimethylaminopropylamide disulphides as alternative substrates for trypanothione reductase fromTrypanosoma crud: Part 3 | Q58850173 | ||
| 3-TrifluoromethylquinoxalineN,N′-Dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-T. cruziAgents and Mechanism of Action Studies | Q58869707 | ||
| Interaction energies of nitrofurans with trypanothione reductase and glutathione reductase studied by molecular docking | Q58869734 | ||
| Electrochemical and microsomal production of free radicals from 1,2,5-oxadiazole N-oxide as potential antiprotozoal drugs | Q58869767 | ||
| P433 | issue | 15 | |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | 1843-1859 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Future Medicinal Chemistry | Q19280078 |
| P1476 | title | Indazoles: a new top seed structure in the search of efficient drugs against Trypanosoma cruzi | |
| P478 | volume | 5 |
Search more.